Cargando…
A 115-bp MethyLight assay for detection of p16 (CDKN2A) methylation as a diagnostic biomarker in human tissues
BACKGROUND: p16 Methylation is a potential biomarker for prediction of malignant transformation of epithelial dysplasia. A probe-based, quantitative, methylation-specific PCR (MSP) called MethyLight may become an eligible method for detecting this marker clinically. We studied oral mucosa biopsies w...
Autores principales: | Zhou, Jing, Cao, Jie, Lu, Zheming, Liu, Hongwei, Deng, Dajun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120739/ https://www.ncbi.nlm.nih.gov/pubmed/21569495 http://dx.doi.org/10.1186/1471-2350-12-67 |
Ejemplares similares
-
Analysis of repetitive element DNA methylation by MethyLight
por: Weisenberger, Daniel J., et al.
Publicado: (2005) -
Establishment of the MethyLight Assay for Assessing Aging, Cigarette Smoking, and Alcohol Consumption
por: Endo, Kosuke, et al.
Publicado: (2015) -
DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight
por: Weisenberger, Daniel J., et al.
Publicado: (2008) -
Novel Multiplex MethyLight Protocol for Detection of DNA Methylation in Patient Tissues and Bodily Fluids
por: Olkhov-Mitsel, Ekaterina, et al.
Publicado: (2014) -
A modified MethyLight assay predicts the clinical outcomes of anti‐epidermal growth factor receptor treatment in metastatic colorectal cancer
por: Ouchi, Kota, et al.
Publicado: (2022)